#5D;6-[[6-ANTHRACEN-9-YL-4-(1H-INDOL-3-YL)-PYRIDAZIN-3-YL]-HYDRAZONO]-3-(3,4,5-TRIHYDROXY-6-HYDROXY-METHYLTETRAHYDROPYRAN-2-YLOXY)-HEXANE-1,2,4,5-TETRAOL
Compound with spectra: 1 NMR
![#5D;6-[[6-ANTHRACEN-9-YL-4-(1H-INDOL-3-YL)-PYRIDAZIN-3-YL]-HYDRAZONO]-3-(3,4,5-TRIHYDROXY-6-HYDROXY-METHYLTETRAHYDROPYRAN-2-YLOXY)-HEXANE-1,2,4,5-TETRAOL](/api/compound/JvDVN4D5KR6.png?ph=true&h=300&w=458 "#5D;6-[[6-ANTHRACEN-9-YL-4-(1H-INDOL-3-YL)-PYRIDAZIN-3-YL]-HYDRAZONO]-3-(3,4,5-TRIHYDROXY-6-HYDROXY-METHYLTETRAHYDROPYRAN-2-YLOXY)-HEXANE-1,2,4,5-TETRAOL")
| SpectraBase Compound ID | JvDVN4D5KR6 |
|---|---|
| InChI | InChI=1S/C38H39N5O10/c44-17-29(47)36(53-38-35(51)34(50)33(49)30(18-45)52-38)32(48)28(46)16-40-42-37-24(25-15-39-26-12-6-5-11-23(25)26)14-27(41-43-37)31-21-9-3-1-7-19(21)13-20-8-2-4-10-22(20)31/h1-16,28-30,32-36,38-39,44-51H,17-18H2,(H,42,43)/b40-16+ |
| InChIKey | BZUXWMNSHPMPLG-YQOHXEDVSA-N |
| Mol Weight | 725.8 g/mol |
| Molecular Formula | C38H39N5O10 |
| Exact Mass | 725.269692 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
SCH-20562
3,5,6,7,8-PENTAMETHOXY-1-O-PRIMEVEROSYL-XANTHONE
D-6-Methyl-8-(beta-L-arabinopyranose-3,4-diacetate-1,2-orthoacetate-methyl)-ergolin-I
3,5-DIMETHOXY-3-(1,1-DIMETHYLPROP-2-ENYL)-3,4-DIHYDROPSORALEN-4-ONE
10.beta.-[2-(3-Trifluoromethylphenyl)allyl]deoxoartemisinin
CREPISIDE I
2-(2',3',4',6'-Tetra-O-acetyl-.beta.-D-glucopyranosylthio)-5,6,7,8-tetrahydrobenzothieno-[2,3-d]pyrimidine-4-thione
ALPHA-TETRASACCHARIDE 1 (FROM PROTEUS HAUSERI)
1,2-Diethyl-3,4-dimethyl 5-(cyclohexylamino)-1H-pyrazole-1,2,3,4(3H)-tetracarboxylate
5,8-Epoxynaphtho[2,3-d]-1,3-dioxole-5(6H)-carboxylic acid, 6-formyl-7,8-dihydro-, methyl ester
| Title | Journal or Book | Year |
|---|---|---|
| An Efficient Synthesis and Reactions of Novel Indol-ylpyridazinone Derivatives with Expected Biological Activity | Molecules | 2007 |